Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Dainese

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
CNS Drugs|November 17, 2021
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Drugs & Aging|March 28, 2022
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Epilepsia|December 11, 2023
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Seizure|March 23, 2022
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Epilepsia|March 12, 2022
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizuresSimona Lattanzi, Michele Ascoli, Laura Canafoglia, et al.
CNS Drugs|September 3, 2021
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurology and Therapy|March 12, 2025
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 9, 2019
Management of epilepsy in brain tumorsMarta Maschio, Umberto Aguglia, Giuliano Avanzini, et al.
Pediatric Neurology|February 11, 2023
Extended Glasgow Outcome Scale to Evaluate the Functional Impairment of Patients With Subcortical Band Heterotopia: A Multicentric Cross-sectional StudyIrene Toldo, Francesco Brunello, Paola Cavasin, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
CNS Drugs|November 17, 2021
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Drugs & Aging|March 28, 2022
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Epilepsia|December 11, 2023
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Seizure|March 23, 2022
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Epilepsia|March 12, 2022
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizuresSimona Lattanzi, Michele Ascoli, Laura Canafoglia, et al.
CNS Drugs|September 3, 2021
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurology and Therapy|March 12, 2025
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 9, 2019
Management of epilepsy in brain tumorsMarta Maschio, Umberto Aguglia, Giuliano Avanzini, et al.
Pediatric Neurology|February 11, 2023
Extended Glasgow Outcome Scale to Evaluate the Functional Impairment of Patients With Subcortical Band Heterotopia: A Multicentric Cross-sectional StudyIrene Toldo, Francesco Brunello, Paola Cavasin, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Pageof 4